N1H- and N1-Substituted Phenylguanidines as alpha 7 Nicotinic Acetylcholine (nACh) Receptor Antagonists: Structure-Activity Relationship Studies
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
N1H- and N1-Substituted Phenylguanidines as alpha 7 Nicotinic Acetylcholine (nACh) Receptor Antagonists : Structure-Activity Relationship Studies. / Alwassil, Osama; Khatri, Shailesh; Schulte, Marvin K.; Aripaka, Sanjay S.; Mikkelsen, Jens D.; Dukat, Malgorzata.
In: ACS Chemical Neuroscience, Vol. 12, No. 12, 2021, p. 2194-2201.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - N1H- and N1-Substituted Phenylguanidines as alpha 7 Nicotinic Acetylcholine (nACh) Receptor Antagonists
T2 - Structure-Activity Relationship Studies
AU - Alwassil, Osama
AU - Khatri, Shailesh
AU - Schulte, Marvin K.
AU - Aripaka, Sanjay S.
AU - Mikkelsen, Jens D.
AU - Dukat, Malgorzata
PY - 2021
Y1 - 2021
N2 - We previously reported that N-(3-chlorophenyl)guanidine (1) represents a novel alpha 7 nicotinic ACh (nACh) receptor antagonist chemotype. In the present study, a small series of compounds was synthesized with the intent to investigate the structure-activity relationship (SAR). Preliminary data suggested that the N-methyl analog of 1, 2, was several times more potent. Therefore, the chloro group at the aryl 3-position of 1 and its N1-methyl counterpart 2 were replaced with a number of substituents considering the electronic, lipophilic, and steric nature of the substituents. The potencies of the compounds to inhibit acetylcholine (ACh)-induced responses were obtained in Xenopus laevis oocytes expressing human alpha 7 nicotinic ACh receptors (nAChRs) using a two-electrode voltage-clamp assay. We found that the nature of the 3-position substituents had relatively little (i.e.,
AB - We previously reported that N-(3-chlorophenyl)guanidine (1) represents a novel alpha 7 nicotinic ACh (nACh) receptor antagonist chemotype. In the present study, a small series of compounds was synthesized with the intent to investigate the structure-activity relationship (SAR). Preliminary data suggested that the N-methyl analog of 1, 2, was several times more potent. Therefore, the chloro group at the aryl 3-position of 1 and its N1-methyl counterpart 2 were replaced with a number of substituents considering the electronic, lipophilic, and steric nature of the substituents. The potencies of the compounds to inhibit acetylcholine (ACh)-induced responses were obtained in Xenopus laevis oocytes expressing human alpha 7 nicotinic ACh receptors (nAChRs) using a two-electrode voltage-clamp assay. We found that the nature of the 3-position substituents had relatively little (i.e.,
KW - alpha 7 nAChR
KW - SAR
KW - electrophysiology
KW - antagonist
KW - phenylguanidines
KW - ALLOSTERIC MODULATORS
KW - ARYLGUANIDINES
KW - BINDING
U2 - 10.1021/acschemneuro.1c00212
DO - 10.1021/acschemneuro.1c00212
M3 - Journal article
C2 - 34043311
VL - 12
SP - 2194
EP - 2201
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
SN - 1948-7193
IS - 12
ER -
ID: 273696892